Is there an indirect way to invest in Genmab A/S?

Direct listed exposure is available, so an indirect proxy is usually unnecessary.

Does Genmab A/S have a stock symbol?

The stock symbol is GMAB on NASDAQ.

Genmab A/S

Status: Publicly traded

Direct answer

Genmab A/S is publicly traded on NASDAQ under the ticker GMAB.

Genmab A/S, a biopharmaceutical company founded in 1999 and headquartered in Copenhagen, Denmark, specializes in the discovery and development of innovative antibody therapies primarily for treating cancer and various other serious illnesses. The company's commercialized portfolio includes several key products: DARZALEX (daratumumab), a human monoclonal antibody for multiple myeloma (MM), non-MM blood cancers, and...

Can you invest in Genmab A/S?

Yes. Genmab A/S trades publicly on NASDAQ as GMAB.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Genmab A/S

Detailed equity research is provided by MarketSnap.